Patents by Inventor Vladyslava Rybka

Vladyslava Rybka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of Kv11.1 channel inhibitors for treatment of pulmonary hypertension
    Patent number: 11529324
    Abstract: Provided are methods of treating pulmonary artery hypertension with a Kv11.1 (ERG or hERG1) channel inhibitor. In certain embodiments, the Kv11.1 channel inhibitor is dofetilide. In certain embodiments, a subject to be treated using a method of the disclosure is not in need of treatment for an irregular heart rhythm, e.g., atrial fibrillation.
    Type: Grant
    Filed: May 21, 2020
    Date of Patent: December 20, 2022
    Assignee: GEORGETOWN UNIVERSITY
    Inventors: Tinatin I. Brelidze, Yuichiro J. Suzuki, Nataliia Shults, Vladyslava Rybka
  • USE OF Kv11.1 CHANNEL INHIBITORS FOR TREATMENT OF PULMONARY HYPERTENSION
    Publication number: 20200383941
    Abstract: Provided are methods of treating pulmonary artery hypertension with a Kv11.1 (ERG or hERG1) channel inhibitor. In certain embodiments, the Kv11.1 channel inhibitor is dofetilide. In certain embodiments, a subject to be treated using a method of the disclosure is not in need of treatment for an irregular heart rhythm, e.g., atrial fibrillation.
    Type: Application
    Filed: May 21, 2020
    Publication date: December 10, 2020
    Inventors: Tinatin I. Brelidze, Yuichiro J. Suzuki, Nataliia Shults, Vladyslava Rybka